Original ArticleDoes cosmetic outcome from treatment of primary breast cancer influence psychosocial morbidity?☆
References (17)
- et al.
Cosmetic evaluation of breast conserving treatment for mammary cancer. 1. Proposal of a quantitative scoring system
Radiother Oncol
(1989) - et al.
The cosmetic outcome in early breast cancer treated with breast conservation
Eur J Surg Oncol
(1999) - et al.
Breast retraction assessment: an objective evaluation of cosmetic results of patients treated conservatively for breast cancer
Int J Radiat Oncol Biol Phys
(1985) - et al.
Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast
Int J Radiat Oncol Biol Phys
(1979) The assessment of body image in cancer patients
Eur J Cancer
(1993)- et al.
Safe selection criteria for breast conservation without radical excision in primary operable invasive breast cancer
Eur J Cancer
(1995) - et al.
Seven-year follow-up on 334 patients treated by breast conserving surgery and short course radical postoperative radiotherapy: a report of the Yorkshire breast cancer group
Clin Oncol
(1995) - et al.
Early breast cancer: influence of type of boost (electrons vs iridium-192 implant) on local control and cosmesis after conservative surgery and radiation therapy
Radiother Oncol
(1995)
There are more references available in the full text version of this article.
Cited by (192)
Measurement of adverse cosmesis in breast cancer: A deep learning approach
2024, Expert Systems with ApplicationsOncoplastic reduction mammoplasty: Systematic review and proportional meta-analysis of surgical outcomes
2024, Journal of Plastic, Reconstructive and Aesthetic SurgeryIn Response to Morgan et al. and Li et al.
2023, International Journal of Radiation Oncology Biology PhysicsTangential Volumetric Modulated Arc Therapy for Locally Advanced Breast Cancer
2022, Practical Radiation OncologyCitation Excerpt :Additional toxicity may be imparted by this additional coverage. Cosmetic changes can cause psychological distress years after treatment.14,15 Patients are also at an increased risk of cardiovascular mortality and secondary malignancies, which are outcomes that are dependent on the dose received by the heart and lungs, respectively.16
Unrecognized thoracic radiotherapy toxicity: A review of literature
2022, Cancer/Radiotherapie
- ☆
This paper was presented at the 56th scientific meeting of the British Association of Surgical Oncology (BASO), 25–26 June 1998.
- f1
Correspondence to: Mr Sharif K. Al-Ghazal, Clinical Research Fellow, Professorial Unit of Surgery, Nottingham City Hospital, Hucknall Road, Nottingham NG5 1PB, UK. Fax. +44 115 962 7765.
Copyright © 1999 Published by Elsevier Ltd. All rights reserved.